Search
Palvella Therapeutics Inc
PVLAAdd to Watchlist
113.100USD
+0.470+0.42%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.62BMarket Cap
LossP/E TTM
Palvella Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Palvella Therapeutics Inc is 9.56, ranking 23 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -27.13, which is -98.91% below the recent high of -0.30 and -117.64% above the recent low of -59.04.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
